Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-08

Clinical Trial Update: Traumatic Optic Neuropathy Treatment Trial 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Traumatic Optic Neuropathy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Iran University of Medical Sciences | Conditions: Traumatic Optic Neuropathy | Phase 3 | Status: COMPLETED